Score Overview
Explore the 2021 public Archive ranking →
Where Heron Therapeuti has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- HRTX
1996: 88.3% · 2018: 97.6% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 0.31 | — |
1 Year2025-09-30 | $ 1.26 | -75.12% |
5 Years2021-09-30 | $ 10.69 | -97.07% |
10 Years2016-09-30 | $ 17.23 | -98.18% |
20 Years2006-09-29 | $ 85.60 | -99.63% |
30 Years1996-09-30 | $ 660.00 | -99.95% |
All Time1987-08-26 | $ 580.00 | -99.95% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-30 | All Time1987-08-26 |
|---|---|---|---|---|---|---|---|
| Price | $ 0.31 | $ 1.26 | $ 10.69 | $ 17.23 | $ 85.60 | $ 660.00 | $ 580.00 |
| Return | — | -75.12% | -97.07% | -98.18% | -99.63% | -99.95% | -99.95% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 151M | -$ 34M | $ 42M |
| 2025 | $ 154M | -$ 20M | $ 46M |
| 2024 | $ 144M | -$ 13M | $ 59M |
| 2023 | $ 127M | -$ 110M | $ 80M |
| 2022 | $ 107M | -$ 134M | $ 84M |
| 2021 | $ 86M | -$ 217M | $ 157M |
| 2020 | $ 88M | -$ 224M | $ 208M |
| 2019 | $ 145M | -$ 204M | $ 390M |
| 2018 | $ 77M | -$ 178M | $ 332M |
| 2017 | $ 30M | -$ 197M | $ 172M |
| 2016 | $ 1M | -$ 173M | $ 51M |
| 2015 | $ 0.00 | -$ 97M | $ 131M |
| 2014 | $ 0.00 | -$ 76M | $ 72M |
| 2013 | $ 0.00 | -$ 55M | $ 72M |
| 2012 | -$ 599K | -$ 23M | $ 53M |
| 2011 | $ 646K | -$ 11M | $ 17M |
| 2010 | $ 1M | -$ 7M | $ 2M |
| 2009 | $ 1M | -$ 10M | $ 7M |
| 2008 | $ 369K | -$ 23M | $ 10M |
| 2007 | $ 412K | -$ 20M | $ 35M |
| 2006 | $ 5M | $ 5M | $ 15M |
| 2005 | $ 5M | -$ 8M | $ 5M |
| 2004 | $ 5M | -$ 9M | $ 13M |
| 2003 | $ 4M | -$ 4M | $ 9M |
| 2002 | $ 5M | -$ 3M | $ 14M |
| 2001 | $ 4M | -$ 2M | $ 19M |
| 2000 | $ 3M | $ 8M | $ 22M |
| 1999 | $ 20M | -$ 2M | $ 3M |
| 1998 | $ 20M | -$ 2M | $ 4M |
| 1997 | $ 17M | -$ 1M | $ 8M |
| 1996 | $ 18M | -$ 9M | $ 5M |
| 1995 | $ 16M | -$ 9M | $ 5M |
| 1994 | $ 15M | -$ 9M | $ 2M |
| 1993 | $ 19M | -$ 9M | $ 1M |
| 1992 | $ 7M | -$ 5M | $ 2M |
| 1991 | $ 2M | -$ 4M | $ 1M |
| 1990 | $ 2M | -$ 3M | $ 1M |
| 1989 | $ 2M | -$ 4M | $ 2M |
| 1988 | $ 2M | -$ 5M | $ 11M |
| IPO1987 | $ 1M | -$ 3M | $ 15M |
Heron Therapeuti fundamental performance
Between 2020 and 2025, revenue grew from $ 88M to $ 154M and net income went from -$ 224M to -$ 20M. Revenue increased in 4 of those 5 years; net income in 3.
Between 2015 and 2025, revenue grew from $ 0.00 to $ 154M and net income went from -$ 97M to -$ 20M. Revenue increased in 7 of those 10 years; net income in 5.
Heron Therapeuti currently holds a 20-year HDB Score of 2.9 out of 10. How the HDB Score is calculated.
Membership
Continue HRTX’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
